| Home | Article Database | Fun Stuff | Resources | Tools & Calculators | Search HY


Ask the Mental Health Expert Archives 2001-2004

Expert Home  |  Archives by Date  |  Search Expert Archives  |  For Professionals  |  For Consumers


OCD Medicines

Q. I was wondering if you know of the effectiveness of Ultram or morphine for Obsessive-Compulsive Disorder (OCD)? There have been several studies that indicate that it may be an effective treatment for refractory OCD. What are your thoughts?

A. I am not aware of any randomized, double-blind, placebo-controlled studies showing that either Tramadol [Ultram] or morphine are useful in treating OCD. Since this type of study is the "gold standard" for scientific research, I'd have to say I remain a skeptic until I see such evidence. That said, I am aware of open studies and case reports finding that opiate-like agents (this includes Tramadol, though this drug also has effects similar to Prozac and other SSRIs) may be useful in some cases of severe, refractory OCD. In Dr. Lorrin Koran's excellent text, "Obsessive-Compulsive and Related Disorders in Adults" (Cambridge, 1999), he summarizes a few of the studies done with opiates. For example, Warneke (1997) reported on the benefits of oral morphine every 5-8 days, in five severely refractory OCD patients. Koran has observed some benefits with oral codeine, though lasting only a few hours. Some interesting new data on Tramadol for OCD has come from the clinic of Dr. Nathan Shapira, at the University of Cincinnati [for details, log on to http://medcenter.uc.edu/news/cTramadol.ucm]. Although Dr. Shapira has not reported randomized, double-blind, placebo-controlled studies, he has observed that, "In some patients, Tramadol can even take affect and decrease symptoms within 30 minutes to an hour. Traditional drugs used to treat these illnesses have to be taken for at least 8-12 weeks before any response is apparent. This drug is unique in that it can be taken on an as-needed basis and can have an immediate response time." Perhaps so, but I await the "gold standard" studies! Given the addictive risks associated with opiates and related agents, I think we all need to be cautious with this approach.

Other Resources:

January 2004

Disclaimer Back to Ask the Expert



 
ADDITIONAL ONLINE RESOURCES FROM CMPMEDICA
Featured Resources > Psychiatry Careers > Today's Practice - Practice Management Resource > Bipolar Depression Infocenter
CancerNetwork > Cancer diagnosis, treatment, and prevention > Podcasts for Oncologists > Cancer Patient Resources > Oncology Areas of Confusion > Oncology News > Cancer Management Handbook > Oncology E-Learning > ASCO Conference Report
Consultant Live > Pediatric Asthma > Practical Clinical Advice > Medical Photoclinic > Diagnosing and Treating H1N1 flu (swine flu) > Primary Care Conference Reports > Community Acquired MRSA
Diagnostic Imaging > Medical Imaging News and Features > Medical Imaging and Radiology White Papers > Radiology Conference Reports > Radiology Special Reports > Radiology Net Seminars > Imaging Trends and Advances > CT Dose Issues and Articles > Molecular Imaging Articles
Psychiatric Times > Psychiatric News and Special Reports > APA Conference Report > Psychiatric Clinical Scales > Psychiatric Times Blog > Psychiatry Career Opportunities > DSM-V
Physicians Practice > Practice Management > EMR Software > Medical Practice Management Software > Medical Buyers Guide > Medical Coding
SearchMedica > Professional Medical Search Engine > Medical Search Tips Newsletter > Medical Search News
CME LLC > Continuing Medical Education > Psychiatry CME > Oncology CME > Practice Management CME > Primary Care CME > Psychiatric Congress > Performance Improvement CME
More Resources > Consumer Healthcare Information > Patient and Caregiver Resource > Search drug information, interactions, images & diagnosis